ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Grifols SA

Grifols SA (GRFS)

7,73
0,19
(2,52%)
Geschlossen 05 Januar 10:00PM
7,73
0,005
(0,06%)
Nach Börsenschluss: 12:47AM

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Current Price
7,73
Gebot
7,35
Fragen
7,83
Volumen
446.487
7,44 Tagesbereich 7,755
0,00 52-Wochen-Bereich 0,00
Marktkapitalisierung
Handelsende
7,54
Handelsbeginn
7,52
Letzte Trade
24
@
7.83
Letzter Handelszeitpunkt
Finanzvolumen
US$ 3.394.229
VWAP
7,6021
Durchschnittliches Volumen (3 Mio.)
-
Ausgegebene Aktien
687.554.908
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
110,66
Gewinn pro Aktie (EPS)
0,09
Erlöse
6,59B
Nettogewinn
59,32M

Über Grifols SA

Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people all over the world. A leader in essential plasma-derived medicines and transfusion medicine we develop produce and provide innovative healthcare services and solutions in mo... Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people all over the world. A leader in essential plasma-derived medicines and transfusion medicine we develop produce and provide innovative healthcare services and solutions in more than 110 countries. Patient needs and our ever-growing knowledge of many chronic rare and prevalent diseases sometimes life-threatening drive our innovation in plasma-based therapies and other biopharmaceuticals to enhance quality of life. Grifols is focused on treating conditions across a broad range of therapeutic areas: immunology hepatology and intensive care pulmonology hematology neurology and infectious diseases. With a workforce of over 27000 employees in more than 30 countries and regions we are committed to a sustainable business model that sets the standard for continuous innovation quality safety and ethical leadership in the industry. Mehr anzeigen

Sektor
Medicinal Chems,botanicl Pds
Branche
In Vitro,in Vivo Diagnostics
Website
Hauptsitz
Barcelona, Catalonia, Esp
Gegründet
1987
Grifols SA is listed in the Medicinal Chems,botanicl Pds sector of the NASDAQ with ticker GRFS. The last closing price for Grifols was US$7,54. Over the last year, Grifols shares have traded in a share price range of US$ 0,00 to US$ 0,00.

Grifols currently has 687.554.908 shares in issue. The market capitalisation of Grifols is US$5,18 billion. Grifols has a price to earnings ratio (PE ratio) of 110.66.

GRFS Neueste Nachrichten

GigaGen Doses First Patient in Phase 1 Trial of Recombinant Polyclonal Drug Candidate, GIGA-2339, for Hepatitis B Virus

SAN CARLOS, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- GigaGen Inc., a biotechnology company advancing transformative antibody drugs for immunodeficiencies, infectious diseases and...

Grifols Receives FDA Approval to Treat Surgical Bleeding in Pediatric Patients With its Fibrin Sealant Solution

Younger patients in the U.S. can now benefit from Grifols Fibrin Sealant (FS) and its positive effect on surgical outcomes, including a fast time to hemostasisGrifols surgical bleeding management...

Grifols Partners with BARDA for Proof-of-Concept Testing of Ocular Immunoglobulin as Treatment for Sulfur Mustard-Induced Eye Injury

Initiative will test Grifols ocular surface immunoglobulin (OSIG) eye drops to evaluate their nonclinical efficacy in neutralizing symptoms from exposure to sulfur mustard, a chemical warfare...

GigaGen Awarded U.S. BARDA Contract to Develop Recombinant Polyclonal Antibody Therapies for Botulinum Neurotoxins and an Additional Biothreat

The contract will provide an initial commitment of $19.6 million and up to $135.2 million over a six-year period, supporting drug manufacturing and phase 1 trials for the two programs GigaGen’s...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

GRFS - Frequently Asked Questions (FAQ)

What is the current Grifols share price?
The current share price of Grifols is US$ 7,73
How many Grifols shares are in issue?
Grifols has 687.554.908 shares in issue
What is the market cap of Grifols?
The market capitalisation of Grifols is USD 5,18B
What is the 1 year trading range for Grifols share price?
Grifols has traded in the range of US$ 0,00 to US$ 0,00 during the past year
What is the PE ratio of Grifols?
The price to earnings ratio of Grifols is 110,66
What is the cash to sales ratio of Grifols?
The cash to sales ratio of Grifols is 1
What is the reporting currency for Grifols?
Grifols reports financial results in EUR
What is the latest annual turnover for Grifols?
The latest annual turnover of Grifols is EUR 6,59B
What is the latest annual profit for Grifols?
The latest annual profit of Grifols is EUR 59,32M
What is the registered address of Grifols?
The registered address for Grifols is CALLE JESUS I MARIA, 6, BARCELONA, CATALONIA, 08174
What is the Grifols website address?
The website address for Grifols is www.grifols.com
Which industry sector does Grifols operate in?
Grifols operates in the IN VITRO,IN VIVO DIAGNOSTICS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
FCUVFocus Universal Inc
US$ 0,9499
(174,93%)
259,78M
NITON2OFF Inc
US$ 2,6306
(145,85%)
350,92M
CRNCCerence Inc
US$ 19,33
(143,76%)
159,55M
KITTNauticus Robotics Inc
US$ 3,8249
(140,56%)
104,78M
ACONAclarion Inc
US$ 0,2984
(110,14%)
305,59M
HWHHWH International Inc
US$ 0,4621
(-28,80%)
7,43M
SMSTDefiance Daily Target 2x Short MSTR ETF
US$ 5,69
(-26,30%)
24,77M
RAINRain Enhancement Technologies Holdco Inc
US$ 5,59
(-23,42%)
161,15k
PTLEPTL Ltd
US$ 9,35
(-23,30%)
1,04M
NXUNXU Inc
US$ 0,725868
(-22,78%)
7,59M
NITON2OFF Inc
US$ 2,6306
(145,85%)
350,92M
TGLTreasure Global Inc
US$ 0,382
(101,58%)
330,82M
ACONAclarion Inc
US$ 0,2984
(110,14%)
305,59M
FCUVFocus Universal Inc
US$ 0,9499
(174,93%)
259,78M
NVDANVIDIA Corporation
US$ 144,47
(4,45%)
222,72M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock